Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Lung Neoplasms 6Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Colorectal Neoplasms 4Neoplasm Metastasis 3Colonic Neoplasms 3Thymoma 2Rectal Neoplasms 2Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Temporomandibular Joint Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Smoking 1Small Cell Lung Carcinoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm, Residual 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Nivolumab 4Biopsy 4Specimen Handling 3Ipilimumab 3CTLA-4 Antigen 3prednylidene 2deltacortene 2Prednisone 2Magnetic Resonance Spectroscopy 2Imiquimod 2Celecoxib 2talimogene laherparepvec 1endonuclease V, phage T4 1Tacrolimus 1Sirolimus 1Microarray Analysis 1Isotretinoin 1Deoxyribonuclease (Pyrimidine Dimer) 1Chemoprevention 1Biological Therapy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Carcinoma, Basal Cell × Celecoxib × Clear all
NCT00023621 2013-06-26

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡